FDA Inspection
Symrise AGSymrise AG – FDA Inspection, Apr 22, 2016
Record Details
This FDA Inspection record concerns Symrise AG, with an inspection on April 22, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Symrise AG
- Inspection Date
- April 22, 2016
- Product Type
- Drugs
View Company Profile
ID · 46ebe67b-971a-42dd-97e0-ef56244936e2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 968502
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Symrise AG
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 5, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 7, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 9, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2013 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
Other documents for Symrise AG
- FDA Inspection 1289898 - 2023-12-05
- FDA Inspection 1135051 - 2020-07-07
- FDA Inspection 1046108 - 2018-03-09
- FDA Inspection 818239 - 2013-02-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.